首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Simultaneous determination of Z-3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone (SU5416) and its interconvertible geometric isomer (SU5886) in rat plasma by LC/MS/MS.
【24h】

Simultaneous determination of Z-3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone (SU5416) and its interconvertible geometric isomer (SU5886) in rat plasma by LC/MS/MS.

机译:通过LC / MS / MS同时测定大鼠血浆中Z-3-((2,4-二甲基吡咯-5-基)亚甲基)-2-吲哚满酮(SU5416)及其可相互转换的几何异构体(SU5886)。

获取原文
获取原文并翻译 | 示例
       

摘要

Z-3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinone (SU5416) is a cytostatic substance in development as an anti-angiogenic agent. SU5416 exists as the thermodynamically stable cis or Z-isomer as a solid. Studies have shown that in light exposed solutions of SU5416, the unstable trans or E-isomer, namely SU5886, is formed. The E-isomer converts back to the Z-isomer when protected from light. The E-isomer is unstable for synthesis and isolation; therefore, the analytical standard of the E-isomer is not available. In this study, a simple, fast and reliable LC/MS/MS method has been developed to determinate both isomers simultaneously in rat plasma samples to support the study of disposition kinetics of SU5416. This method is sensitive (limit of quantitation (LOQ=0.5ng/mL)), reproducible and has a wide linear range (0.5-2500ng/mL). There was no conversion between E- and Z-isomer during sample preparation procedure and sample determination with LC/MS/MS. Experimental results proved that SU5416 and SU5886 have identical detection response. Therefore, SU5416 (Z-isomer) was used successfully as analytical standard for SU5886 (E-isomer). This method has been applied to rat plasma samples obtained from a pharmacokinetic study. This study underscores the use of LC/MS/MS technique for bioanalytical methods where analytical standards are not available and analytes are interconvertible.
机译:Z-3-[(2,4-二甲基吡咯-5-基)亚甲基] -2-吲哚满酮(SU5416)是一种发展中的细胞生长抑制物质,可作为抗血管生成剂。 SU5416以热力学稳定的顺式或Z-异构体形式存在。研究表明,在SU5416的曝光溶液中,会形成不稳定的反式或E-异构体,即SU5886。当避光时,E-异构体会转换回Z-异构体。 E-异构体对于合成和分离不稳定。因此,没有电子异构体的分析标准品。在这项研究中,已开发出一种简单,快速且可靠的LC / MS / MS方法来同时测定大鼠血浆样品中的两种异构体,以支持SU5416处置动力学的研究。该方法灵敏(定量限(LOQ = 0.5ng / mL)),可重现,线性范围广(0.5-2500ng / mL)。在样品制备过程和使用LC / MS / MS进行样品测定期间,E和Z异构体之间没有转化。实验结果证明SU5416和SU5886具有相同的检测响应。因此,SU5416(Z-异构体)已成功用作SU5886(E-异构体)的分析标准品。该方法已应用于从药代动力学研究中获得的大鼠血浆样品。这项研究强调了LC / MS / MS技术在无法获得分析标准品且分析物可互换的生物分析方法中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号